Literature DB >> 32499909

Is diet partly responsible for differences in COVID-19 death rates between and within countries?

Jean Bousquet1,2,3,4, Josep M Anto5,6,7,8, Guido Iaccarino9, Wienczyslawa Czarlewski10,11, Tari Haahtela12, Aram Anto10, Cezmi A Akdis13, Hubert Blain14,15, G Walter Canonica16, Victoria Cardona17, Alvaro A Cruz18, Maddalena Illario19,20, Juan Carlos Ivancevich21,22, Marek Jutel23, Ludger Klimek24, Piotr Kuna25, Daniel Laune26, Désirée Larenas-Linnemann27, Joaquim Mullol28, Nikos G Papadopoulos29,30, Oliver Pfaar31, Boleslaw Samolinski32, Arunas Valiulis33, Arzu Yorgancioglu34, Torsten Zuberbier1,2,3,4.   

Abstract

Reported COVID-19 deaths in Germany are relatively low as compared to many European countries. Among the several explanations proposed, an early and large testing of the population was put forward. Most current debates on COVID-19 focus on the differences among countries, but little attention has been given to regional differences and diet. The low-death rate European countries (e.g. Austria, Baltic States, Czech Republic, Finland, Norway, Poland, Slovakia) have used different quarantine and/or confinement times and methods and none have performed as many early tests as Germany. Among other factors that may be significant are the dietary habits. It seems that some foods largely used in these countries may reduce angiotensin-converting enzyme activity or are anti-oxidants. Among the many possible areas of research, it might be important to understand diet and angiotensin-converting enzyme-2 (ACE2) levels in populations with different COVID-19 death rates since dietary interventions may be of great benefit.
© The Author(s) 2020.

Entities:  

Keywords:  Angiotensin-converting enzyme; Antioxidant; Coronavirus; Diet; Food

Year:  2020        PMID: 32499909      PMCID: PMC7250534          DOI: 10.1186/s13601-020-00323-0

Source DB:  PubMed          Journal:  Clin Transl Allergy        ISSN: 2045-7022            Impact factor:   5.871


Introduction

A novel strain of human coronaviruses, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), named by the International Committee on Taxonomy of Viruses (ICTV) [1], has emerged and caused an infectious disease referred to as “coronavirus disease 2019” (COVID-19) by the World Health Organization (WHO) [2]. COVID-19 has aggressively spread across the globe and over 160,000 deaths have been reported. However, there appears to be high- and low-death rate countries. After the outbreak in China, COVID-19 has also affected Europe after becoming a pandemic. Interestingly, there is large variability across European countries in both incidence and mortality, and most current debates on COVID-19 focus on the differences among countries. German fatalities are strikingly low as compared to many European countries. Among the several explanations proposed, an early and large testing of the population was put forward [3]. However, little attention has been given to regional differences and diet [4].

Biases to be considered

According to the Johns Hopkins coronavirus resource center (https://coronavirus.jhu.edu), one of the most important ways of measuring the burden of COVID-19 is mortality. However, death rates are assessed differently between countries and there are many biases that are almost impossible to assess. Differences in the mortality rates depend on the characteristics of the health care system, the reporting method, whether or not deaths outside the hospital have been counted and other factors, many of which remain unknown. Countries throughout the world have reported very different case fatality ratios—the number of deaths divided by the number of confirmed cases—but these numbers cannot be compared at all due to biases. On the other hand, for many countries, the methodology reporting death rates in the different regions is standardized across the country.

European data on death rates per million inhabitants

We used the Johns Hopkins coronavirus resource center to assess death rates at the national level (https://coronavirus.jhu.edu). The current death rate per million people in Europe shows different trends. Germany has a low death rate, but Austria, the Czech Republic, Poland, Slovakia, the Baltic States and Finland have similar or lower rates. On the other hand, Belgium, France, Italy, Spain and the UK have higher rates (Fig. 1).
Fig. 1

COVID-19 deaths per million inhabitants in Europe (April 17, 2020). For France, deaths included hospital and extra-hospital deaths

COVID-19 deaths per million inhabitants in Europe (April 17, 2020). For France, deaths included hospital and extra-hospital deaths Large differences exist when assessing death rates within a country. In Germany, Bavaria started the earliest tests but was and still is the most affected region (Fig. 2). Death rates per million range from 8 in Mecklenburg-Vorpommern to 87 in Bavaria.
Fig. 2

Regional COVID-19 death rates per million in four European countries

Regional COVID-19 death rates per million in four European countries In Switzerland, the French and Italian speaking cantons have a far higher death rate than the German-speaking ones (Fig. 3) (Office fédéral de la santé publique, Switzerland, https://www.bag.admin.ch/bag/fr/home.html).
Fig. 3

COVID-19 rates in Switzerland (Office fédéral de la santé publique). Cas confirmés en laboratoire (laboratory confirmed cases), distribution géographique (geographical distibution), cas décédés (death rate)

COVID-19 rates in Switzerland (Office fédéral de la santé publique). Cas confirmés en laboratoire (laboratory confirmed cases), distribution géographique (geographical distibution), cas décédés (death rate) In high-rate countries such as Spain, large variations also exist within the country, but the numbers range from 115 in Murcia to over 1000 in Madrid.

Is diet partly involved in different death rates between countries?

Most diseases exhibit large geographical variations which frequently remain unexplained despite abundant research [5]. COVID-19 will not be an exception. Though the more relevant factors are likely to be seasonal variations, immunity, cross-immunity, intensity, timing of measures [6], type, onset, duration and measures of protection, other factors like environment or nutrition should not be overlooked. Obesity, a risk factor of mortality in COVID-19, suggests the importance of nutrition [7]. The “low-rate” European countries have used different quarantine and/or confinement times and methods and none have performed as many early tests as Germany. Thus, although the German testing approach is very important [3], other factors may also be significant.

Immunity in COVID-19 and ageing

Although there are large differences between countries in death rates, the age-dependent severity of COVID-19 is similar between Asian, European and American countries. The rate of deaths is increased in the older population. Globally, there are risk factors for death including obesity and type 2 diabetes. A strong relationship between hyperglycemia, impaired insulin pathway, and cardiovascular disease in type 2 diabetes is linked to oxidative stress and inflammation [8]. Lipid metabolism has an important role to play in obesity, diabetes and its multi-morbidities, and the ageing process [9]. Dietary fatty acids have a significant role in immune responses [10]. Many foods have an antioxidant activity [11-13]. Resveratrol, present in many foods [14], is an inhibitor of MERS-Coronavirus infection [15].

Angiotensin-converting enzyme 2 (ACE-2)

The angiotensin-converting enzyme (ACE2) has multiple physiological roles: a negative regulator of the renin-angiotensin system, facilitator of amino acid transport, and the SARS-CoV and SARS-CoV-2 receptor [16]. ACE converts angiotensin I to angiotensin II but ACE2 catalyses the conversion of angiotensin II to angiotensin and is also the main entry point for coronavirus 2 into cells. Differences between countries in ACE have been associated with genetic patterns. The ACE D allele increased risk of vasculitis [17] or hypertension [18]. The ACE I/D polymorphism is involved in the onset of type 2 diabetes [19] and might be associated with susceptibility to peripheral vascular diseases in the Asian population [20]. However, dietary patterns have a strong effect on ACE levels. A high-saturated fat diet increases ACE [21]. Many foods have an ACE-inhibitory activity [22-24]. Anti-oxidant activities and ACE inhibition have been largely found in many foods [25]. Moreover, ACE levels in blood are highly and rapidly sensitive to food intake [26]. Identifying whether countries with high or low ACE activity have different death rates would be of great interest in understanding the clinical importance of interventions. However, the available evidence, in particular from human studies, does not seem to support the hypothesis that inhibitors of ACE or renin-angiotensin–aldosterone (ACEI/ARB) drugs increase the ACE2 expression and the risk of COVID-19 [27]. This might suggest that changes in ACE expression (inhibition/stimulation) might not be as relevant as previously thought and other diet-related changes might be more (or equally) important.

Possible interactions between diet and COVID-19 death rate

Germany, Austria, Croatia, the Czech Republic, Poland, Slovakia, the Baltic States and German-speaking Swiss cantons exhibit lower COVID-19 mortality rates than France, Italy, Spain, and the French and Italian speaking Swiss cantons. Among many factors, diet differs considerably between these low- or high-mortality countries. It appears that death rates in Germany are higher in the two Southern Regions as well as in Saarland than elsewhere. Baden-Wurttemberg and Saarland are in close contact with Alsace (France), and the higher infection rate may be due to the high cross-border traffic of the French. However, this was not the case for Rhineland-Palatinate (lower death rate), possibly because the East Region of France was contaminated later. In addition, Saarland is a special case as half of the deaths, unlike in the other German states, occurred in only a few long-term care facilities where a high number of people were infected in a short time and all deaths during the episode were attributed to Corona without autopsies being made. This potential French-based contamination does not apply for Bavaria (earliest German region to be contaminated and highest death rate). Diet differs within Germany, the southern states traditionally having a higher fat-rich diet. Diet is not normally distributed within country/region, which can be an additional argument in favour of the uneven distribution of mortality. Nutrition may therefore play a role in the immune defense against COVID-19 and may explain some of the differences seen in COVID-19 across Europe. It will be needed to test dietary differences between low and high-rate countries. Foods with potent antioxidant or anti ACE activity—like uncooked or fermented cabbage [28-30]—are largely consumed in low-death rate European countries, Korea and Taiwan, and might be considered in the low prevalence of deaths. Although it is difficult to compare health systems and death reporting across European countries, Bulgaria, Greece and Romania have very low death rates. This might also be associated with diet since cabbage (Romania) and fermented milk (Bulgaria and Greece) are common foods. The latter food is a known ACE natural inhibitor [31]. Turkey, another apparently low-death rate country, also consumes a lot of cabbage and fermented milk products. Another example may be the food supply chain. The increasing availability of foods from big retail is a revolutionary event that has impacted crops (favouring those that have the best ratio of effectiveness over costs of production) and health at a population-size level. In particular, such a change in food availability has altered alimentary habits—promoting sugar-enriched, vitamin-depauperated foods—and has become one of the causes of the obesity epidemic, especially among adolescents. These foods come from centralized farms in selected areas of the world that are distributed around the planet, elongating the supply chain of food. The impact of long supply chain of food on health is measurable by an increase in metabolic syndrome and insulin resistance [32]. Therefore, rural areas that are more prone to short supply food may have been able to better tolerate the COVID-19 pandemia, with a lower death toll. These considerations may be partly involved in lower death rates in Southern Italy compared to the Northern part.

Conclusions

Understanding the within and between country differences in COVID-19 will be of paramount importance in understanding COVID-19 risk and protective factors, and will eventually help to control the epidemics. We acknowledge that many factors may play a role in the extension and severity of COVID-19, such as trained immunity of the population, early and fast education, rapid organization and adaptation of the hospitals and the public, preparedness for pandemics and public hygiene. Diet represents only one of the possible causes of the COVID-19 epidemic and its importance needs to be better assessed.
  35 in total

Review 1.  Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications.

Authors:  Raphaela I Lau; Fen Zhang; Qin Liu; Qi Su; Francis K L Chan; Siew C Ng
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-10-21       Impact factor: 73.082

2.  The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review.

Authors:  Philip T James; Zakari Ali; Andrew E Armitage; Ana Bonell; Carla Cerami; Hal Drakesmith; Modou Jobe; Kerry S Jones; Zara Liew; Sophie E Moore; Fernanda Morales-Berstein; Helen M Nabwera; Behzad Nadjm; Sant-Rayn Pasricha; Pauline Scheelbeek; Matt J Silver; Megan R Teh; Andrew M Prentice
Journal:  J Nutr       Date:  2021-07-01       Impact factor: 4.798

3.  Correlates of In-Hospital COVID-19 Deaths: A Competing Risks Survival Time Analysis of Retrospective Mortality Data.

Authors:  Ashish Goel; Alpana Raizada; Ananya Agrawal; Kamakshi Bansal; Saurabh Uniyal; Pratima Prasad; Anil Yadav; Asha Tyagi; R S Rautela
Journal:  Disaster Med Public Health Prep       Date:  2021-03-25       Impact factor: 1.385

Review 4.  Gut Microbiota, in the Halfway between Nutrition and Lung Function.

Authors:  Christophe Espírito Santo; Catarina Caseiro; Maria João Martins; Rosário Monteiro; Inês Brandão
Journal:  Nutrients       Date:  2021-05-19       Impact factor: 5.717

5.  Mediterranean Diet and SARS-COV-2 Infection: Is There Any Association? A Proof-of-Concept Study.

Authors:  Valentina Ponzo; Marianna Pellegrini; Chiara D'Eusebio; Fabio Bioletto; Ilaria Goitre; Silvio Buscemi; Simone Frea; Ezio Ghigo; Simona Bo
Journal:  Nutrients       Date:  2021-05-19       Impact factor: 5.717

6.  HANA: A Healthy Artificial Nutrition Analysis model during COVID-19 pandemic.

Authors:  Mahmoud Y Shams; Omar M Elzeki; Lobna M Abouelmagd; Aboul Ella Hassanien; Mohamed Abd Elfattah; Hanaa Salem
Journal:  Comput Biol Med       Date:  2021-06-30       Impact factor: 4.589

Review 7.  Theoretical benefits of yogurt-derived bioactive peptides and probiotics in COVID-19 patients - A narrative review and hypotheses.

Authors:  Ahmed S Gouda; Fatima G Adbelruhman; Hamedah Sabbah Alenezi; Bruno Mégarbane
Journal:  Saudi J Biol Sci       Date:  2021-06-18       Impact factor: 4.052

Review 8.  Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID‑19 (Review).

Authors:  Sergej Nadalin; Hrvoje Jakovac; Vjekoslav Peitl; Dalibor Karlović; Alena Buretić-Tomljanović
Journal:  Mol Med Rep       Date:  2021-06-29       Impact factor: 2.952

Review 9.  Intestinal Barrier Function in Health and Disease-Any role of SARS-CoV-2?

Authors:  Lakshya Sharma; Antonio Riva
Journal:  Microorganisms       Date:  2020-11-06

10.  COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper.

Authors:  Oliver Pfaar; Ludger Klimek; Marek Jutel; Cezmi A Akdis; Jean Bousquet; Heimo Breiteneder; Sharon Chinthrajah; Zuzana Diamant; Thomas Eiwegger; Wytske J Fokkens; Hans-Walter Fritsch; Kari C Nadeau; Robyn E O'Hehir; Liam O'Mahony; Winfried Rief; Vanitha Sampath; Manfred Schedlowski; María José Torres; Claudia Traidl-Hoffmann; De Yun Wang; Luo Zhang; Matteo Bonini; Randolf Brehler; Helen Annaruth Brough; Tomás Chivato; Stefano R Del Giacco; Stephanie Dramburg; Radoslaw Gawlik; Aslı Gelincik; Karin Hoffmann-Sommergruber; Valerie Hox; Edward F Knol; Antti Lauerma; Paolo M Matricardi; Charlotte G Mortz; Markus Ollert; Oscar Palomares; Carmen Riggioni; Jürgen Schwarze; Isabel Skypala; Eva Untersmayr; Jolanta Walusiak-Skorupa; Ignacio J Ansotegui; Claus Bachert; Anna Bedbrook; Sinthia Bosnic-Anticevich; Luisa Brussino; Giorgio Walter Canonica; Victoria Cardona; Pedro Carreiro-Martins; Alvaro A Cruz; Wienczyslawa Czarlewski; João A Fonseca; Maia Gotua; Tari Haahtela; Juan Carlos Ivancevich; Piotr Kuna; Violeta Kvedariene; Désirée Erlinda Larenas-Linnemann; Amir Hamzah Abdul Latiff; Mika Mäkelä; Mário Morais-Almeida; Joaquim Mullol; Robert Naclerio; Ken Ohta; Yoshitaka Okamoto; Gabrielle L Onorato; Nikolaos G Papadopoulos; Vincenzo Patella; Frederico S Regateiro; Bolesław Samoliński; Charlotte Suppli Ulrik; Sanna Toppila-Salmi; Arunas Valiulis; Maria-Teresa Ventura; Arzu Yorgancioglu; Torsten Zuberbier; Ioana Agache
Journal:  Allergy       Date:  2021-03       Impact factor: 14.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.